hydrazine and ly 53857
hydrazine has been researched along with ly 53857 in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Anderson, HV; Buja, LM; De Clerck, F; Golino, P; NcNatt, JM; Rosolowsky, M; Willerson, JT; Yao, SK | 1 |
Ashton, JH; Buja, LM; Glas-Greenwalt, P; Golino, P; McNatt, J; O'Brien, RA; Willerson, JT; Yao, SK | 1 |
Ashton, JH; Buja, LM; Golino, P; McNatt, JM; Willerson, JT | 1 |
Mehta, JL; Yang, BC | 1 |
Brooks, RM; Heistad, DD; Kaul, S; Padgett, RC; Waack, BJ | 1 |
Chung, JH; Chung, SM; Lee, JY; Lee, MY | 1 |
Other Studies
6 other study(ies) available for hydrazine and ly 53857
Article | Year |
---|---|
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Epinephrine; Epoprostenol; Ergolines; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Pentanoic Acids; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin Antagonists; Thromboxane A2; Thromboxane-A Synthase | 1990 |
Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Ergolines; Fatty Acids, Unsaturated; Hydrazines; Myocardial Reperfusion; Platelet Aggregation; Recombinant Proteins; Recurrence; Serotonin; Serotonin Antagonists; Thromboxane A2; Time Factors; Tissue Plasminogen Activator | 1989 |
Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.
Topics: Animals; Blood Flow Velocity; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Coronary Disease; Dogs; Epinephrine; Ergolines; Fatty Acids, Unsaturated; Female; Hemodynamics; Hydrazines; Male; Receptors, Prostaglandin; Receptors, Thromboxane; Serotonin Antagonists; Yohimbine | 1989 |
Platelets increase the tone of quiescent rat aortic rings by release of serotonin and potentiate the subsequent contractile response to norepinephrine.
Topics: Amino Acid Oxidoreductases; Animals; Aorta, Thoracic; Apyrase; Arginine; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Endothelium, Vascular; Ergolines; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Thromboxane A2 | 1994 |
Interaction of human platelets and leukocytes in modulation of vascular tone.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adenosine Diphosphate; Animals; Arginine; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Carotid Artery, Common; Ergolines; Fatty Acids, Unsaturated; Humans; Hydrazines; In Vitro Techniques; Muscle Tonus; Muscle, Smooth, Vascular; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nitroarginine; Nitroprusside; Phenylephrine; Platelet Activation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Receptors, Thromboxane; Serotonin Antagonists; Superoxide Dismutase; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1994 |
Chemically induced platelet lysis causes vasoconstriction by release of serotonin.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Endothelium, Vascular; Ergolines; Fatty Acids, Unsaturated; Hemostatics; Hydrazines; In Vitro Techniques; Ketanserin; L-Lactate Dehydrogenase; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vitamin K | 1998 |